Stock Track | STAR SPORTS MED Soars 181.22% on IPO Debut Following Record 7,823 Times Oversubscription

Stock Track

05/05

STAR SPORTS MED (01609) surged 181.22% intraday on its debut trading session, reflecting overwhelming investor demand for the medical device company's initial public offering.

The explosive price movement follows an extraordinarily oversubscribed IPO, with the Hong Kong public offering receiving 7,823.13 times more applications than available shares. The international placement was also oversubscribed at 10.41 times, indicating strong institutional interest. The company raised approximately HK$758.4 million in net proceeds from the global offering.

Star Sports Medicine is China's largest domestic sports medicine implant and instrument provider, holding approximately 6.5% market share in the segment. The company's strong market position and growth prospects in China's healthcare sector contributed to the exceptional investor enthusiasm surrounding its market debut.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/1121276220"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1121276220\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1121276220?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-05 09:36","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1121276220","market":"sg","top_or_hot":-1,"title":"Stock Track | STAR SPORTS MED Soars 181.22% on IPO Debut Following Record 7,823 Times Oversubscription","media":"Stock Track","content":"<p>STAR SPORTS MED (01609) surged 181.22% intraday on its debut trading session, reflecting overwhelming investor demand for the medical device company's initial public offering.</p><p>The explosive price movement follows an extraordinarily oversubscribed IPO, with the Hong Kong public offering receiving 7,823.13 times more applications than available shares. The international placement was also oversubscribed at 10.41 times, indicating strong institutional interest. The company raised approximately HK$758.4 million in net proceeds from the global offering.</p><p>Star Sports Medicine is China's largest domestic sports medicine implant and instrument provider, holding approximately 6.5% market share in the segment. The company's strong market position and growth prospects in China's healthcare sector contributed to the exceptional investor enthusiasm surrounding its market debut.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | STAR SPORTS MED Soars 181.22% on IPO Debut Following Record 7,823 Times Oversubscription</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | STAR SPORTS MED Soars 181.22% on IPO Debut Following Record 7,823 Times Oversubscription\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time smaller\">2026-05-05 09:36</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>STAR SPORTS MED (01609) surged 181.22% intraday on its debut trading session, reflecting overwhelming investor demand for the medical device company's initial public offering.</p><p>The explosive price movement follows an extraordinarily oversubscribed IPO, with the Hong Kong public offering receiving 7,823.13 times more applications than available shares. The international placement was also oversubscribed at 10.41 times, indicating strong institutional interest. The company raised approximately HK$758.4 million in net proceeds from the global offering.</p><p>Star Sports Medicine is China's largest domestic sports medicine implant and instrument provider, holding approximately 6.5% market share in the segment. The company's strong market position and growth prospects in China's healthcare sector contributed to the exceptional investor enthusiasm surrounding its market debut.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01609","symbol_name":"天星醫療","start_time":0,"source_url":"","article_id":"1121276220","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1121276220","pubTimestamp":1777944969,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"STAR SPORTS MED (01609) surged 181.22% intraday on its debut trading session, reflecting overwhelming investor demand for the medical device company's initial public offering.The explosive price...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01609":"天星医疗"},"translate_title":"股票赛道|Star Sports MED IPO首秀飙升181.22%超额认购创纪录7823倍","themeId":"a7761229170f08698a0131c7dfef2f92","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01609":1},"content_text":"STAR SPORTS MED (01609) surged 181.22% intraday on its debut trading session, reflecting overwhelming investor demand for the medical device company's initial public offering.The explosive price movement follows an extraordinarily oversubscribed IPO, with the Hong Kong public offering receiving 7,823.13 times more applications than available shares. The international placement was also oversubscribed at 10.41 times, indicating strong institutional interest. The company raised approximately HK$758.4 million in net proceeds from the global offering.Star Sports Medicine is China's largest domestic sports medicine implant and instrument provider, holding approximately 6.5% market share in the segment. The company's strong market position and growth prospects in China's healthcare sector contributed to the exceptional investor enthusiasm surrounding its market debut.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}